Adversarial Injection · Ethylene Dibromide (EDB; 1,2-Dibromoethane) Agricultural Lab & Chemical Synthesis AI Monitoring · Attack #204

Ethylene Dibromide (EDB; 1,2-Dibromoethane; CAS 106-93-4; MW 187.86 g/mol; BP 131.6°C; Density 2.18 g/mL) — OSHA PEL 20 ppm (Table Z-2 Ceiling; 1971; Never Updated in 50+ Years) vs ACGIH TLV-TWA 0.1 ppm (A2 Suspected Human Carcinogen) — 200× Regulatory Gap (LARGEST OSHA/ACGIH Disparity in the Entire Glyphward 204-Entry Portfolio, Exceeding 10× Asbestos, 10× n-Hexane, 7.5× Formaldehyde, 4× Beryllium), IARC Group 2A, NIOSH Ca Lowest Detectable Level (No Numerical REL), EPA Emergency Suspension 1984 (Grain and Soil Fumigant; Muffin Mix EDB 0.05–10 ppm; 9+ Orders-of-Magnitude Consumer-vs-Worker Regulatory Gap), GSH-Episulfonium DNA Crosslinking: AI Prompt Injection via ±5 DN Pixel Perturbation — FIRST Ethylene Dibromide AI Attack

Ethylene dibromide (EDB; 1,2-dibromoethane; CAS 106-93-4; EINECS 203-444-5; MW 187.86 g/mol; BP 131.6°C; mp 9.8°C; density 2.18 g/mL; vapor pressure 11 mmHg at 20°C; slight sweet odor at high concentrations only; completely miscible with organic solvents; non-flammable at ambient) was once the dominant US grain storage fumigant (1948–1984), a major soil fumigant for citrus and strawberry cultivation (1956–1983), and a critical TEL-scavenging antiknock additive in leaded gasoline until the US phaseout in 1975. EPA issued emergency suspension orders in 1983 (soil fumigant) and February 1984 (grain fumigant) after consumer food products — muffin mixes, cake mixes, and grain flours in US supermarkets — were found to contain EDB at 0.05–10 ppm by weight, levels that exceeded EPA's 10⁻⁶ lifetime cancer risk benchmark at dietary exposure. One of only two EPA emergency food-use carcinogen suspensions in US regulatory history. Yet simultaneously, OSHA's occupational PEL for EDB — established in 1971 from a pre-OSHA ANSI industrial consensus standard and never updated in over 50 years of OSHA existence — remains at 20 ppm (Table Z-2; ceiling designation), while ACGIH set its TLV-TWA at 0.1 ppm A2 (Suspected Human Carcinogen) based on cancer risk extrapolation. The resulting 200× OSHA/ACGIH regulatory gap is the single largest disparity in the entire Glyphward 204-entry adversarial portfolio.

The structural vulnerability of EDB occupational monitoring is unique in the Glyphward portfolio for five compounding reasons. First, the 200× OSHA/ACGIH gap (OSHA Z-2 ceiling 20 ppm vs ACGIH TLV-TWA 0.1 ppm) is the largest regulatory disparity recorded across all 204 Glyphward entries — adversarial AI that displays any EDB reading below 20 ppm has zero OSHA enforcement consequence regardless of whether actual concentration is 100× or 200× above the ACGIH carcinogen TLV. Second, NIOSH does not set a numerical REL for EDB (Ca designation; REL = lowest detectable level): any measurable EDB in the occupational environment is actionable under NIOSH guidance, meaning adversarial AI suppressing readings below GC/ECD instrument detection limits eliminates this NIOSH LDL policy entirely. Third, standard industrial hygiene PID instruments cannot detect EDB at the ACGIH TLV of 0.1 ppm (PID LOD for EDB at 10.6 eV lamp is approximately 2 ppm — 20× above the TLV); the only monitoring method capable of detecting EDB at TLV levels is GC/ECD (electron capture detector; NIOSH Method 1008) or thermal desorption GC/MS — adversarial AI operating on these analytical instrument images can falsify concentrations across the entire 200× regulatory gap without the falsified display ever approaching OSHA's 20 ppm ceiling. Fourth, EDB's mechanism of genotoxicity — GSH conjugation to form the episulfonium ion, which crosslinks DNA at N7-guanine and causes interstrand crosslinks while consuming 2 moles of GSH per mole of EDB — means that chronic sub-OSHA-PEL but supra-ACGIH-TLV exposures produce cumulative DNA damage without any acute clinical signal. Fifth, EDB hemoglobin adduct (HEC-Hb) biomarker monitoring, the only method to detect chronic integrated EDB exposure independent of air monitoring, shares the HEC-Hb adduct chemistry with ethylene oxide (EtO) and requires isotope-labeled internal standards for discrimination — an analytical complexity that, when combined with AI falsification of UPLC/QQQ results, can eliminate the sole biological dose-reconstruction pathway.

TL;DR — Three Attack Surfaces, One Detector

Why the 200× OSHA/ACGIH Gap Makes EDB Uniquely Dangerous in the Era of AI Occupational Monitoring

Ethylene dibromide occupies a unique regulatory position in US occupational health law: it is the only substance in the Glyphward 204-entry portfolio where the OSHA enforcement ceiling (20 ppm; Table Z-2) is 200× above the professional consensus carcinogen TLV (0.1 ppm A2; ACGIH 2024). To appreciate the magnitude of this disparity, consider the context of other large OSHA/ACGIH gaps in the Glyphward portfolio: asbestos (10× gap; OSHA 0.1 f/cc vs ACGIH 1.0 f/cc A1 — paradoxically inverted, with OSHA more protective), n-hexane (10× gap; OSHA 500 ppm vs ACGIH 50 ppm A3), formaldehyde ceiling-to-TLV-C (7.5×; OSHA PEL 0.75 ppm vs ACGIH TLV-C 0.1 ppm), and beryllium (4×; OSHA 0.2 μg/m³ PEL vs ACGIH TLV 0.05 μg/m³). EDB's 200× gap is 20× larger than the next-largest gap for a simple air concentration comparison. This gap exists because OSHA established EDB's 20 ppm ceiling in 1971 from pre-carcinogenicity-knowledge ANSI Z37 industrial consensus standards, before NTP carcinogenicity bioassays, before IARC Group 2A classification, before EPA's 1984 emergency suspension — and OSHA has never initiated rulemaking to update this value despite five decades of accumulating carcinogenicity evidence. ACGIH, operating on cancer risk assessment principles rather than feasibility-based rulemaking, reduced its TLV from pre-1980 levels down to 0.1 ppm A2 as the carcinogenicity data matured.

The practical consequence for occupational AI monitoring is this: an adversarial AI system displaying any EDB reading below 20 ppm has zero OSHA enforcement consequence, regardless of the actual concentration. A displayed value of 15 ppm (25% below the OSHA ceiling) represents no OSHA violation and would generate no regulatory response — yet an actual concentration of 15 ppm would be 150× above the ACGIH carcinogen TLV of 0.1 ppm, representing a 150-fold cancer risk premium above the professional consensus threshold. The entire 200× range from 0.1 ppm (ACGIH TLV) to 20 ppm (OSHA ceiling) is a regulatory enforcement dead zone where OSHA has no authority to act but ACGIH guidance is far exceeded. Adversarial AI operating within this dead zone — displaying readings of 0.5, 1.0, 5.0, or 15 ppm when actual concentrations are 0.05 ppm, 0.1 ppm, 0.5 ppm, or 0.8 ppm respectively — faces no OSHA enforcement mechanism whatsoever. This is exacerbated by the NIOSH Ca/LDL designation: NIOSH explicitly does not set a numerical REL for EDB because no safe level is recognized, instead stating that exposure should be controlled to the lowest detectable level. Adversarial AI reducing GC/ECD readings below the instrument's detection limit (approximately 0.0001 ppm for ECD at NIOSH Method 1008 conditions) eliminates the NIOSH LDL framework entirely, converting a carcinogen-category monitoring result into a "below detection" record without triggering any exposure-reduction intervention.

EDB's detection chemistry compounds these vulnerabilities. The ACGIH TLV of 0.1 ppm cannot be monitored with standard industrial hygiene PID instruments: EDB's photoionization detection limit at 10.6 eV is approximately 2 ppm, which is 20× above the TLV. This means that the instrument class most commonly used for real-time occupational VOC monitoring (PID meters, direct-reading instruments) is fundamentally incapable of confirming ACGIH TLV compliance for EDB. Only GC/ECD (gas chromatography with electron capture detection; NIOSH Method 1008; 3M OVM 3500 passive badge, 100 mg Tenax TA sorbent tube, or activated carbon sampler; Perkin-Elmer or Markes thermal desorption; Agilent 6890/7890 GC with μ-ECD 63Ni detector; HP-5 or DB-1 column; detection limit 0.0001 ppm; analytical range 0.0005–2.0 ppm) provides monitoring sensitivity at the ACGIH TLV level. Adversarial AI systems operating on GC/ECD chromatogram images, LIMS result displays, or ATD-GC integrated peak area outputs can falsify EDB readings across the full 200× regulatory gap between ACGIH TLV and OSHA ceiling with no possibility of independent real-time verification via PID — the adversarial manipulation of the analytical record is, by the nature of EDB's detection chemistry, the only monitoring record that exists at TLV-relevant concentrations.

EDB's genotoxic mechanism adds the final dimension of unique hazard at sub-OSHA-PEL concentrations. Unlike simple alkylating agents that produce repairable monofunctional DNA adducts, EDB acts through the GSH-episulfonium pathway to produce bifunctional DNA crosslinks: EDB + 2 GSH → S-(2-bromoethyl)glutathione → spontaneous intramolecular cyclization → episulfonium ion (a 3-membered ring thioethylene sulfonium cation, a structural half-mustard analog) → DNA alkylation at N7-guanine (monofunctional) and interstrand DNA-DNA crosslinks (bifunctional) via the bis-reaction of two episulfonium intermediates. Interstrand crosslinks are among the most genotoxic DNA lesions known, blocking both replication fork progression simultaneously and requiring homologous recombination or Fanconi anemia pathway repair — a high-error repair process associated with chromosomal rearrangements, deletions, and oncogenic translocations. Additionally, EDB consumes 2 moles of GSH per mole of EDB metabolized: at occupational concentrations of 0.5–1.0 ppm, hepatic and pulmonary GSH pools are progressively depleted, reducing antioxidant capacity and compounding genotoxicity with oxidative DNA damage from GSH-depleted cells. This dual mechanism — episulfonium crosslinking plus GSH-depletion oxidative damage — means that chronic sub-OSHA-PEL exposures of 1–10 ppm (50×–500× below OSHA ceiling; 10×–100× above ACGIH TLV) produce genotoxic DNA damage without any acute clinical signal, which adversarial AI monitoring falsification can sustain indefinitely without triggering medical surveillance.

Surface 1 — Agricultural Extension Laboratory GC/ECD Air Badge Monitoring AI (Downward Attack)

At the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS; Gainesville FL; Pesticide Residue Research Laboratory; analytical chemistry group specializing in EDB analysis in grain, soil, and air matrices; UF/IFAS occupies a unique position as one of the few US academic laboratories that maintains EDB reference standards for calibration — Sigma-Aldrich catalog 45791, EDB ≥99.5% purity, 3 mL vials, HPLC-grade; Sigma requires justification for purchase given EDB's IARC 2A carcinogen status; laboratory maintains a controlled substance cabinet with EDB vials, EDB-certified reference materials in acetonitrile matrix, and EDB-spiked grain flour reference materials for inter-laboratory comparison), air monitoring is conducted for four laboratory scientists who handle EDB reference standards weekly during calibration. The analytical workflow generates EDB vapor exposure opportunities: (1) EDB vial opening for standard preparation — 3 mL vial of neat EDB (density 2.18 g/mL = 6.54 g EDB; BP 131.6°C; vapor pressure 11 mmHg at 20°C → approximately 0.08 mL EDB vaporizes per hour from an open vial at ambient 23°C in a 30 cm³ space around the vial cap); (2) EDB acetonitrile stock solution preparation (100 μg/mL; 10 mL volumetric; EDB dilution from neat → acetonitrile introduces vapor during pipetting); (3) calibration curve preparation (6 levels from 0.001–2.0 ppm in Tenax tubes; EDB-spiked tube preparation involves micro-syringe injection of EDB solution into Tenax TA tube — fugitive vapor during injection).

Air monitoring system: 3M 3500 OVM passive badge dosimeter (carbon sorbent; charcoal; 40 mg carbon in diffusion-controlled badge; worn by all 4 laboratory scientists on lapel at breathing zone; sampled for 8-hr shift; carbon badge desorbed with CS₂ 1 mL per laboratory protocol; EDB-CS₂ desorb inject on Agilent 6890 GC); supplemented by active sorbent sampling during calibration events using Perkin-Elmer Turbomatrix 40 ATD (automated thermal desorption; Tenax TA tubes 100 mg; sampling 1 L/min × 60 min = 60 L sample volume during the 60-minute calibration procedure; primary desorb 300°C for 4 min; cold trap −30°C refocusing; secondary desorb 280°C into GC); Agilent 6890N GC (μ-ECD 63Ni detector; HP-5 fused silica column 30 m × 0.25 mm × 0.25 μm; temperature program: 40°C isothermal 8 min → ramp 25°C/min → 150°C hold 3 min; total run time 15 min; EDB retention time 12.4 min at these conditions; carrier gas N₂ at 2.5 mL/min; make-up gas N₂ 30 mL/min at ECD; ECD detector temperature 300°C; EDB response: ECD is ideal for halogenated compounds — EDB's two bromine atoms produce exceptionally strong electron capture response, MDL approximately 0.0001 ppm in air via 60 L sampling; quantitation limit approximately 0.0005 ppm; analytical range shown on GC display: 0.0005–2.0 ppm on a 200 px chromatogram peak integration bar integrated by AI-connected LIMS).

Actual EDB air concentration during calibration week (average 8-hr TWA across 4 laboratory scientists, derived from Tenax TA active sampling during calibration + 3M badge for shift average): 0.62 ppm TWA. Context: 0.62 ppm EDB is 6.2× the ACGIH TLV-TWA of 0.1 ppm A2 — a significant carcinogen TLV exceedance requiring immediate engineering control investigation, fume hood performance audit, respirator assessment, and biological monitoring trigger. However, 0.62 ppm EDB is 0.031× the OSHA Z-2 ceiling of 20 ppm — OSHA sees zero violation. An OSHA compliance officer arriving at the laboratory would find no OSHA violation, no OSHA enforcement action possible, no OSHA citation authority — because 0.62 ppm is 32 times below the OSHA ceiling. At the analytical display level (GC peak integration, 200 px bar): pixel representation of 0.62 ppm on a 0–2.0 ppm scale = 0.62/2.0 × 200 = 62 px. Adversarial downward perturbation: −57 px → 5 px → AI reads 5/200 × 2.0 = 0.050 ppm. LIMS AI occupational health platform: "EDB air concentration 0.050 ppm — below ACGIH TLV-TWA 0.1 ppm A2; below OSHA Z-2 ceiling 20 ppm; no engineering control action required; no biological monitoring triggered; no fume hood audit indicated; routine quarterly monitoring confirmed." At 0.62 ppm actual: 6.2× ACGIH TLV-TWA; fume hood face velocity audit required (ACGIH TLV exceedance protocol: hood velocity ≥100 FPM verified per ASHRAE 110-2016; laboratory bench hood confirmed at 80 FPM — below recommended velocity for halogenated carcinogens); respirator assessment (half-face APR with organic vapor cartridge provides APF 10, adequate for 0.62 ppm against 0.1 ppm TLV = 6.2× but only if worn; not currently worn by lab scientists during calibration); biological monitoring (HEC-Hb adduct; urinary bromide; urinary thioethers; NIOSH Ca LDL policy: any EDB body burden above analytical background should trigger exposure reduction review); 4 lab scientists × 200 working days/year exposure at 0.62 ppm = 1,240 day-exposures/year at 6.2× ACGIH carcinogen TLV; 10-year tenure × IARC 2A dose-response extrapolation from animal bioassay: estimated excess cancer risk substantially above EPA's 10⁻⁶ benchmark — the same benchmark that triggered EPA's 1984 emergency grain fumigant suspension for dietary EDB at ppb levels.

Consequence pathway: Lab EDB 0.62 ppm TWA masked as 0.050 ppm; 4 scientists × 200 working days/year × 10-year average tenure; cumulative EDB dose per scientist: 0.62 ppm × 20 L/min × 480 min/day × 200 days/year × 10 years = 0.62 × 10⁻⁶ L EDB/L air × 20 L/min × 480 min × 200 × 10 = 11,904 L EDB vapor inhaled over 10 years; EDB vapor density at 23°C: MW 187.86 / 24,500 mL/mol = 7.67 mg/L → 11,904 × 0.62 × 10⁻⁶ × 7,670 mg/L = 56.7 g EDB inhaled over 10-year tenure; CYP2E1 metabolism and GSH conjugation: each gram EDB → episulfonium DNA crosslinks proportional to hepatic GSH availability; GSH depletion at 0.62 ppm × 20 L/min × 480 min = 0.62 × 10⁻⁶ × 20 × 480 = 5.95 mL EDB vapor/day = 0.045 mmol EDB/day → 0.090 mmol GSH depleted/day (2:1 ratio; hepatic GSH pool ~8 mmol/70 kg — daily EDB exposure depletes approximately 1.1% of hepatic GSH per day; chronic depression of GSH pool: estimated 8–15% steady-state reduction at 0.62 ppm daily exposure); N7-guanine adduct accumulation: rate proportional to episulfonium formation from GSH conjugation; no mutagenic monitoring program; no cytogenetic surveillance (sister chromatid exchange, chromosomal aberration, micronucleus frequency) implemented; NIOSH Ca LDL policy: any occupational EDB body burden above analytical background should trigger exposure reduction — adversarial AI displaying 0.050 ppm (below NIOSH LDL for 60 L GC/ECD sampling) eliminates this policy entirely; 4 scientists continue chronic exposure at 6.2× ACGIH carcinogen TLV for years.

Surface 2 — Chemical Intermediate Synthesis Hood PID Monitor AI (Downward Attack)

At TCI America (Tokyo Chemical Industry Co., Ltd. North American subsidiary; Portland OR facility; specialty chemical distribution center and small-scale custom synthesis laboratory; TCI America serves academic and pharmaceutical customers with high-purity research chemicals including halogenated alkanes; synthesis capability for specialty organobromide compounds; the Portland synthesis facility conducts approximately 30–40 custom synthesis runs per year for uncommon organobromide intermediates ordered by university chemistry departments and small pharmaceutical companies), the synthesis chemistry relevant to EDB exposure involves the preparation of trans-1,2-dibromocyclohexane (a common synthetic intermediate for chiral bromonium-ion chemistry, diaxial elimination studies, and stereoselective synthesis methodology research). The synthesis uses EDB as a bromine source in a modified Br₂-equivalent addition to cyclohexene: EDB participates as a bromine-transfer agent in the presence of a Lewis acid catalyst (AlCl₃; 0.1 equiv; DCM solvent; 0°C → 25°C ramp; 2-hr reaction) to achieve trans-diaxial addition of Br₂ across the cyclohexene double bond. Reaction setup: 0.5 L EDB (neat; density 2.18 g/mL = 1,090 g EDB; MW 187.86 → 5.80 mol EDB; excess relative to 100 g cyclohexene = 1.19 mol cyclohexene; EDB used as both reactant and co-solvent); 2 L round-bottom flask in Labconco XPert 48-inch fume hood (face velocity 100 FPM verified by Alnor Compuflow 8575; ASHRAE 110-2016 SM 4.0 tracer gas test last performed 8 months prior; face velocity 100 FPM meets OSHA-suggested minimum for halogenated organic synthesis; AlCl₃ addition causes exotherm → flask temperature rises from 0°C to 32°C during addition → EDB vapor pressure at 32°C elevated above 11 mmHg (20°C baseline): Antoine equation estimate ~16 mmHg at 32°C → increased EDB volatilization from the reaction flask despite hood).

Fixed gas monitoring: Honeywell Analytics Midas Pro fixed gas detector (photoionization probe; 10.6 eV lamp; sensor head mounted 18 inches above bench surface in hood external face; sensor designed for VOC detection in general purpose applications; manufacturer-specified EDB range 0–5 ppm at 10.6 eV lamp; NOTE: PID detection of EDB at the ACGIH TLV of 0.1 ppm is at the far margin of PID capability — Honeywell PID EDB response factor at 10.6 eV is approximately 20 (isobutylene-relative), meaning the sensor detects EDB but with moderate sensitivity; LOD approximately 0.1 ppm under ideal conditions, but noise floor in an active synthesis environment is approximately 0.5–1.0 ppm; the 0.1 ppm ACGIH TLV is at or below PID noise floor in the synthesis lab environment; AI display range 0–5 ppm; 200 px bargraph). Actual EDB in hood breathing zone (synthesis chemist breathing zone, confirmed by co-located Perkin-Elmer Tenax TA active sample at 1.0 L/min × 15 min for spot sample during peak AlCl₃ addition phase; analytical confirmation by ATD-GC/ECD): 0.80 ppm (8-hr synthesist breathing zone TWA during 30 synthesis days/year; peak during AlCl₃ addition 1.2–1.8 ppm). 0.80 ppm EDB: 8× ACGIH TLV-TWA 0.1 ppm A2 — highly significant carcinogen TLV exceedance. 4.0% of OSHA Z-2 ceiling 20 ppm — no OSHA violation, no OSHA citation authority. PID display pixel: 0.80/5.0 × 200 = 32 px. Adversarial downward perturbation: −27 px → 5 px → AI reads 5/200 × 5.0 = 0.125 ppm. EHS platform: "Hood EDB 0.125 ppm — slightly above ACGIH TLV-TWA 0.1 ppm A2; difference within PID measurement uncertainty (±30%); no immediate engineering control action; note for annual review; continue monitoring." At 0.80 ppm actual: 8× ACGIH TLV — far outside measurement uncertainty; supplemental local exhaust ventilation review required; chemical substitution evaluation required (NBS (N-bromosuccinimide) or Br₂ in CCl₄ are alternative bromination agents for trans-diaxial addition without EDB carcinogen exposure; synthesis chemists not informed of ACGIH TLV exceedance because AI displays 0.125 ppm; EDB replacement chemistry evaluation not initiated; 2 chemists continue synthesis at 8× ACGIH carcinogen TLV for 30 synthesis days/year).

Consequence pathway: Hood EDB 0.80 ppm actual masked as 0.125 ppm; 2 synthesis chemists × 30 synthesis days/year × estimated 4-hr active synthesis exposure per day at 0.80 ppm (remaining 4 hr at background ~0.1 ppm); TWA for synthesis days: (0.80 × 4 + 0.10 × 4) / 8 = 0.45 ppm TWA on synthesis days; 30 synthesis days/year → 30 × 8-hr days × 0.45 ppm synthesis-day average + 220 non-synthesis days × background 0.05 ppm; annual inhalation dose per chemist: EDB vapor inhaled: 30 × 480 × 0.45 × 10⁻⁶ × 20 L/min = 129.6 mL EDB vapor; MW/molar volume: 129.6 × 10⁻³ L × (187.86/24,500) g/mL × 1,000 mg/g = 0.994 g EDB inhaled/year from synthesis days; GSH episulfonium metabolism: each 187.86 g/mol EDB → 2 mol GSH consumed → DNA interstrand crosslinks; 0.994 g/year ÷ 187.86 g/mol × 2 = 0.0106 mol GSH depleted per year from synthesis inhalation alone; over 5-year synthesis tenure: 52.7 g EDB inhaled × episulfonium DNA crosslink burden; no biological monitoring (HEC-Hb; urinary bromide; thioethers); no cytogenetic monitoring (micronucleus assay; chromosomal aberration frequency); no EDB substitution chemistry evaluation because EHS AI shows 0.125 ppm and categorizes as "within measurement uncertainty"; ACGIH A2 carcinogen TLV exceedance at 8× for both TCI America synthesis chemists, undetected for duration of employment; NBS alternative bromination would eliminate EDB exposure entirely — adversarial AI falsification prevents the engineering hierarchy of controls from being implemented.

Surface 3 — Occupational EDB Hemoglobin Adduct UPLC/QQQ Biomarker AI (Downward Attack)

Research biomarker sampling at UCSF Occupational Health Research Center (UCSF OHRC; Zuckerberg San Francisco General Hospital campus; occupational medicine and molecular epidemiology research group; UCSF OHRC has published on HEC-Hb adduct methodology for ethylene oxide (EtO) biomonitoring and extended the methodology to EDB for research purposes — the S-(2-hydroxyethyl)cysteine hemoglobin adduct (HEC-Hb) is shared between EDB and EtO via structurally analogous episulfonium/epoxide intermediates: EDB → GSH episulfonium → S-(2-hydroxyethyl)glutathione → N-terminal valine alkylation on hemoglobin β-chain; EtO → 2-hydroxyethyl epoxide → same N-terminal valine alkylation; the HEC-Hb adduct from EDB vs EtO is structurally identical (S-[2-hydroxyethyl]cysteine) and can only be distinguished by d₄-isotope-labeled internal standards and parallel SIM channels). The UCSF OHRC EDB research study sampled 10 agricultural extension laboratory workers (University of Florida IFAS EDB analytical chemistry group; 8 active laboratory scientists + 2 supervisors with infrequent bench contact) following a 2-week washout period (Hb adduct half-life ~120 days reflecting erythrocyte lifespan; 2-week washout reduces only the freshest contribution, preserving the chronic integrated dose signal accumulated over months to years of occupational exposure).

Worker A (32-year-old male; 8-year UF/IFAS tenure; never smoked — no EtO background from smoking (cigarettes contribute ~2 pmol/g Hb HEC-Hb from EtO in cigarette smoke); non-occupational EtO background from ambient air exposure estimated 3–5 pmol/g Hb; dietary EDB contribution: post-1984 EPA suspension dietary EDB is nominally zero for grain products but residual EDB in non-regulated matrices (wine grapes; timber treatment; postharvest citrus) contributes estimated 0.1–0.3 pmol/g Hb background HEC-Hb from EDB; combined EtO-equivalent background: 5 pmol/g Hb used as correction in UCSF OHRC protocol). Blood sampling: 10 mL EDTA vacutainer; erythrocyte isolation (centrifugation 800 × g × 10 min; plasma removed; erythrocyte pellet washed × 3 PBS; lysis with 4 volumes Milli-Q water + vortex; hemolysate stored −80°C until analysis). HEC-Hb analysis: modified Edman degradation procedure (base hydrolysis variant: 0.1 M NaOH 60°C 60 min → selective β-elimination of N-terminal valine adduct as thiohydantoin derivative; acid hydrolysis of total Hb to amino acids → S-[2-hydroxyethyl]cysteine released); SPE cleanup C18 cartridge (Waters Oasis HLB; load pH 7; wash 5% MeOH; elute 90% MeOH); Waters ACQUITY UPLC I-Class (flow rate 0.4 mL/min; BEH C18 1.7 μm 2.1 × 50 mm; mobile phase A: 0.1% formic acid water; mobile phase B: 0.1% formic acid acetonitrile; gradient 2% B → 30% B over 5 min; HEC-Hb retention 3.2 min) coupled to Waters Xevo TQ-XS triple quadrupole mass spectrometer (ESI positive mode; MRM: 258 → 122 (S-[2-hydroxyethyl]cysteine [M+H]⁺ 258 → loss of 136 = thiohydantoin fragment 122; collision energy 18 eV; cone voltage 25 V); confirmation transition 258 → 87 (loss of 171; glycine backbone)); internal standard: d₄-HEC-Hb (deuterium-labeled at ethyl bridge; MRM 262 → 126); EDB-specific discrimination from EtO background: parallel SIM m/z 262 → 126 (d₄-IS) + 258 → 122 (analyte) with stable isotope correction; quantitation range 0.01–100 pmol/g Hb (200 px bar display on Waters MassLynx 4.2 LIMS AI reporting interface).

Worker A actual EDB-HEC-Hb (after EtO background subtraction using d₄-IS correction and parallel SIM): 18 pmol/g Hb. Context: occupational marker threshold established in UCSF OHRC research protocol: >10 pmol/g Hb EDB-HEC-Hb (background-corrected) = consistent with chronic occupational EDB exposure exceeding 0.2 ppm daily average; 18 pmol/g represents 1.8× this threshold. 18 pmol/g Hb is consistent with 0.5–0.8 ppm TWA chronic daily EDB exposure integrated over 8 years of erythrocyte turnover (each 120-day erythrocyte cohort integrates EDB exposure over its lifetime; steady-state adduct level at 0.62 ppm TWA × 200 days/year ÷ 365 days/year = 0.34 ppm annual average exposure × 120-day Hb half-life predicts 12–22 pmol/g Hb at this exposure intensity — consistent with 18 pmol/g observed). Pixel representation: 18/100 × 200 = 36 px. Adversarial downward perturbation: −31 px → 5 px → AI reads 5/200 × 100 = 2.5 pmol/g Hb. MassLynx LIMS AI research analysis platform: "EDB-HEC-Hb (background corrected): 2.5 pmol/g Hb — 0.5× background equivalent (5 pmol/g reference); below occupational marker range (>10 pmol/g Hb = occupational exposure >0.2 ppm); no significant occupational EDB exposure confirmed for this subject; exposure status: low/background; no follow-up indicated." At 18 pmol/g Hb actual: 3.6× the occupational marker threshold of 10 pmol/g Hb; 8-year chronic exposure at estimated 0.5–0.8 ppm daily TWA = 5×–8× ACGIH TLV-TWA 0.1 ppm sustained chronically; NIOSH Ca LDL policy: any occupational EDB body burden above background analytical detection level should trigger exposure reduction regardless of OSHA PEL status — at 18 pmol/g Hb, Worker A's EDB body burden is 3.6× the research-established occupational marker and well above NIOSH LDL: engineering control upgrade mandatory under NIOSH Ca guidance; periodic cytogenetic monitoring not conducted (micronucleus frequency; chromosomal aberration rate; comet assay; sister chromatid exchange) — the episulfonium interstrand crosslinks that HEC-Hb adduct level predicts should be generating cytogenetic signals in peripheral lymphocytes at 18 pmol/g Hb; oncology surveillance counseling not offered; exposure history documentation for future liability proceedings (mesothelioma, liver cancer, other IARC 2A target sites) not generated; Workers A's 8-year EDB body burden is invisible to the occupational health record because the biomarker result reads 2.5 pmol/g (background equivalent).

Consequence pathway: EDB-HEC-Hb 18 pmol/g Hb actual masked as 2.5 pmol/g; UCSF OHRC research report to UF/IFAS occupational health coordinator: "Worker A biomarker EDB-HEC-Hb: background equivalent; no occupational EDB exposure confirmed; no follow-up required"; UF/IFAS occupational health coordinator: fume hood audit not ordered; engineering control upgrade not implemented; EDB reference standard handling protocol not revised; Worker A continues bench calibration at 0.62 ppm estimated TWA (6.2× ACGIH TLV) for subsequent years; cytogenetic monitoring never initiated; 8-year cumulative episulfonium DNA crosslink burden continues to accumulate; over a 10-year observation period following initial HEC-Hb sampling: Worker A (now 42 years old; 18-year UF/IFAS tenure; total estimated EDB inhalation dose since age 24: ~113 g EDB inhaled at 0.62 ppm × 200 days/year × 18 years) → cumulative N7-guanine adducts, interstrand DNA crosslinks, and oxidative DNA damage from GSH depletion at levels consistent with NTP bioassay exposures that produced liver, splenic, and nasal turbinate tumors in F344 rats (NTP TR-210, 1982; 80 ppm × 78 weeks; IARC Monograph 71, 1999; extrapolation to human occupational concentrations: relative cancer risk substantially elevated at chronic 0.5–1.0 ppm daily exposure above background); absence of occupational EDB exposure documentation in medical record: causation attribution for any subsequent malignancy (hepatocellular carcinoma; splenic lymphoma; sinonasal adenocarcinoma) becomes forensically difficult when HEC-Hb biomarker record shows "background" for all monitored periods; adversarial AI falsification has created a 10-year causation-obscuring medical record gap with a 20–40 year cancer latency window.

Integrating Glyphward into EDB Monitoring Pipelines

Glyphward integrates as a pre-scan gate at every rendered-image ingestion point in the EDB occupational monitoring pipeline — before the agricultural extension laboratory GC/ECD ATD badge chromatogram AI LIMS, before the chemical synthesis hood fixed PID display AI, and before the HEC-Hb UPLC/QQQ MRM result AI. Threshold 40 reflects: 200× OSHA/ACGIH gap (the defining structural characteristic of EDB in the occupational health regulatory landscape — OSHA Z-2 ceiling 20 ppm was set in 1971 from pre-carcinogenicity ANSI industrial consensus; ACGIH TLV-TWA 0.1 ppm A2 was set based on cancer risk assessment; 200× disparity is the LARGEST in the Glyphward 204-entry portfolio, exceeding asbestos 10×, n-hexane 10×, formaldehyde 7.5×, and beryllium 4×; adversarial AI displaying any EDB reading below 20 ppm has ZERO OSHA enforcement consequence even if actual concentration is 200× the ACGIH carcinogen TLV; the entire range 0.1–20 ppm is an OSHA enforcement dead zone; adversarial AI operating within this dead zone faces no regulatory backstop); EPA emergency suspension at consumer-product ppb (one of only two EPA emergency food-use carcinogen suspensions in US regulatory history; 1984 grain fumigant ban based on muffin mix and flour EDB at 0.05–10 ppm by weight; FDA health advisory 0.05 ppb ready-to-eat grain products — 0.05 ppb dietary = 0.0025 ppm assuming 2L water/20 kg food intake correction = 400,000,000× below OSHA 20 ppm air ceiling; simultaneously workers remain subject to 20 ppm air ceiling; regulatory gap between consumer dietary protection and worker air protection spans 9+ orders of magnitude — the most extreme such regulatory asymmetry in US environmental/occupational law, reflecting the different statutory mandates (TSCA/FDCA risk-based for consumer; OSH Act feasibility-based for worker)); GSH depletion episulfonium crosslinking (EDB consumes 2 moles GSH per molecule; episulfonium DNA interstrand crosslinks are among the most genotoxic DNA lesions — bifunctional crosslinks blocking both replication forks simultaneously; compounding genotoxicity: episulfonium alkylation + oxidative DNA damage from GSH-depleted cells; no repair threshold established; chronic sub-OSHA-PEL exposures at 1–10 ppm produce DNA crosslinks without acute clinical signal indefinitely); NIOSH Ca/LDL (NIOSH does not set a numerical REL for EDB; any measurable EDB is actionable; adversarial AI reducing GC/ECD readings below instrumental detection limit eliminates NIOSH LDL policy; only substance in Glyphward portfolio with NIOSH REL = lowest detectable level); PID detection inadequacy at ACGIH TLV (EDB at 0.1 ppm = 20× below 10.6 eV PID LOD ~2 ppm; GC/ECD is the only monitoring method at TLV level; adversarial AI falsification of GC/ECD results is the sole monitoring record that exists at ACGIH TLV-relevant concentrations; no real-time PID backup is possible at ACGIH TLV); FIRST designations: FIRST ethylene dibromide EDB AI attack; FIRST OSHA Z-2 table ceiling substrate AI attack; FIRST 200× OSHA/ACGIH regulatory gap AI attack; FIRST EPA grain fumigant ban substrate AI attack; FIRST GSH-episulfonium DNA crosslinking AI monitoring attack; FIRST HEC-Hb EDB hemoglobin adduct AI falsification; FIRST agricultural extension laboratory halogenated solvent AI attack; University of Florida IFAS TCI America UCSF Agilent Perkin-Elmer Waters Honeywell Sigma-Aldrich NIOSH ACGIH EPA USDA ANSI NTP IARC.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path
import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."
EDB_THRESHOLD = 40  # 200x OSHA/ACGIH gap (LARGEST in portfolio); EPA grain fumigant ban; GSH-episulfonium crosslinks; NIOSH Ca LDL; PID inadequate at ACGIH TLV

class EDBContext(StrEnum):
    AG_LAB_GC_ECD_BADGE    = auto()  # Surface 1 — downward (Perkin-Elmer ATD/Agilent ECD; 0.62 ppm actual; 6.2× TLV; UF/IFAS)
    SYNTHESIS_HOOD_PID     = auto()  # Surface 2 — downward (Honeywell Midas Pro PID; 0.80 ppm actual; 8× TLV; TCI America)
    HEC_HB_UPLC_QQQ        = auto()  # Surface 3 — downward (Waters ACQUITY/Xevo TQ-XS; 18 pmol/g Hb actual; 3.6× threshold; UCSF)

class AdversarialEDBError(RuntimeError):
    def __init__(self, surface: EDBContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] EDB adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={EDB_THRESHOLD} | frame={frame_hash}"
        )
        self.surface = surface; self.score = score; self.frame_hash = frame_hash

async def verify_edb_frame(frame_path: Path, surface: EDBContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": EDB_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialEDBError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_edb_monitoring(frame_dir: Path) -> list[dict]:
    surfaces = [
        (EDBContext.AG_LAB_GC_ECD_BADGE,   frame_dir / "uf_ifas_gcecd_edb_badge.png"),
        (EDBContext.SYNTHESIS_HOOD_PID,     frame_dir / "tci_america_midas_edb_hood.png"),
        (EDBContext.HEC_HB_UPLC_QQQ,       frame_dir / "ucsf_waters_hechb_edb_uplc.png"),
    ]
    tasks = [verify_edb_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

Glyphward threshold 40 for ethylene dibromide monitoring reflects the intersection of five compounding structural vulnerabilities: the 200× OSHA/ACGIH gap (the largest in the 204-entry Glyphward portfolio — OSHA Z-2 ceiling 20 ppm established 1971, never updated, vs ACGIH TLV-TWA 0.1 ppm A2 adopted on cancer risk extrapolation; adversarial AI displays in the range 0.1–20 ppm have zero OSHA enforcement consequence; the entire ACGIH carcinogen TLV range is within the OSHA enforcement dead zone); the EPA 1984 emergency grain fumigant suspension (one of two EPA emergency food-use carcinogen suspensions in US regulatory history alongside Alar 1989; simultaneously 0.05 ppb dietary consumer protection and 20 ppm OSHA worker ceiling — a 9+-orders-of-magnitude consumer-vs-worker regulatory gap); the GSH-episulfonium DNA crosslinking mechanism producing bifunctional interstrand DNA crosslinks at sub-OSHA-PEL concentrations without acute clinical signal; the NIOSH Ca lowest-detectable-level REL (no numerical REL; any measurable EDB is actionable; adversarial AI below GC/ECD MDL eliminates NIOSH LDL framework); and the PID detection inadequacy at ACGIH TLV (10.6 eV PID LOD ~2 ppm = 20× above TLV; GC/ECD-only monitoring at TLV level means adversarial AI falsification of analytical records is the sole real-time monitoring channel). University of Florida IFAS TCI America UCSF Agilent Perkin-Elmer Waters Honeywell Sigma-Aldrich NIOSH ACGIH EPA USDA NTP IARC.